Clinical Trials Logo
  1. Home
  2. Other
  3. NCT03979612

Evaluation of the Adhesion to the GENEPY Network — GENEPY  

Hereditary Breast and Ovarian Cancer Clinical Trial

Official title:
Evaluation of the Adhesion to the Network of Care of People at Genetic Risk of Cancer in Midi-Pyrénées (GENEPY)

Clinical Trial Summary

In order to best meet the needs of all those affected by the genetic risk of cancer in our region, it is important to identify the factors likely to influence the course leading to the GENEPY surveillance network. The aim of this study is to evaluatie the adhesion to the network of care of people at genetic risk of cancer in Midi-Pyrénées (GENEPY).

Clinical Trial Description

This network has been open since November 2015 for people who are genetically predisposed to breast / ovarian cancer. The extension to digestive pathologies (HNPCC syndrome, PAF) is in progress. It concerns not only the persons carrying a mutation also those belonging to a family without identified mutation but whose risk of predisposition is important.

The GENEPY network is based on a collaboration between oncogenetic consultations in the region and professionals practicing in institutions (private, public) and liberal: general practitioners, gynecologists, radiologists, oncologists, gastroenterologists, psychologists ...

It is therefore a multicentric and multidisciplinary network, which aims to promote the local care of people genetically predisposed (or considered at high risk of genetic predisposition), while ensuring a high level of competence, to guarantee an optimal and equitable care on the whole of Midi Pyrenees.

The diagnosis of a new genetic disease in an individual is likely to have implications for other family members who may themselves be at risk of developing the disease and / or passing it on to their children.

The inclusion of subjects in the GENEPY network follows the genealogical study of a case (index) : relatives are identified as potentially at risk. In accordance with the recommendations, but also generally at the wish of the patients, the index case is then asked to inform its relatives and to propose them to go to an oncogenetic consultation of their choice. If these people reside in the Midi Pyrenees Toulouse oncogenetic consultation is open to them. If following this consultation a mutation is identified or that their genetic risk is considered important, they are proposed to join the GENEPY network for their monitoring. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03979612
Study type Observational [Patient Registry]
Source Institut Claudius Regaud
Contact Edith Chipoulet, Msc
Phone 0531156009
Email chipoulet.edith@iuct-oncopole.fr
Status Not yet recruiting
Phase
Start date August 1, 2019
Completion date December 31, 2020
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT03246841 - Investigation of Tumour Spectrum of Germline Mutations in Breast and Ovarian Cancer Genes. N/A
Completed NCT03421327 - Genetic Risk: Whether, When, and How to Tell Adolescents
Terminated NCT04668521 - Multifactorial Risk Assessment for Breast & Ovarian Cancer Risk Detection
Completed NCT03075540 - Enhancing At-risk Latina Women's Use of Genetic Counseling for Hereditary Breast and Ovarian Cancer N/A
Enrolling by invitation NCT05721326 - Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition N/A
Recruiting NCT04407611 - Scalable Communication Modalities for Returning Genetic Research Results N/A
Recruiting NCT02302742 - Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
Recruiting NCT02516540 - Efficacy of Lifestyle Intervention in BRCA1/2 Mutation Carriers N/A
Recruiting NCT05409222 - Study of Quality of Life Post Salpingo-oophorectomy in BRCA1/2 & PALB2 Mutation Carriers (BRCA-HRT)
Completed NCT02324062 - Cancer Genetics Hereditary Cancer Panel Testing N/A
Enrolling by invitation NCT05130606 - CONTIGO - Informing Latinas About HBOC Risk N/A
Completed NCT03511690 - Testing an Intelligent Tutoring System to Enhance Genetic Risk Assessment N/A
Completed NCT02087592 - Feasibility of Lifestyle Intervention in BRCA1/2 Mutation Carriers N/A
Active, not recruiting NCT01608074 - Radical Fimbriectomy for Young BRCA Mutation Carriers N/A
Terminated NCT04508764 - Implementation of the Families Accelerating Cascade Testing Toolkit (FACTT) for Hereditary Breast and Ovarian Cancer and Lynch Syndrome N/A
Recruiting NCT03050268 - Familial Investigations of Childhood Cancer Predisposition
Completed NCT02786147 - Identification and Referral of Women at Risk for Hereditary Breast/Ovarian Cancer
Recruiting NCT03124212 - Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and Lynch Syndrome in Switzerland